Drugs · Entity Annotation Prototype (beta)

1articles mentioning drugs

1drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: interleukin (IL)−17 ×

interleukin (IL)−17

This drug is selected. Its supporting articles are shown below.

interleukin (IL)−171

Articles mentioning interleukin (IL)−17

1 articles · page 1 of 1

Design and methods of the Ixekizumab Diabetes Intervention Trial (I-DIT): protocol for a phase 2, randomised, multicentre, placebo-controlled, double-blind trial of anti-interleukin 17 as a treatment option for adults with new-onset type 1 diabetes

bmjopen · abstract · 2025-11-12 · 1 matching annotations

79.7%

interleukin (IL)−17 Type 1 diabetes Swedish Ethical Review Authority Swedish Medical Products Agency

…gressive loss of pancreatic beta cells. Studies have shown that interleukin (IL)−17 is likely a mediator for this destruction. Whether inhibition o…

Browse drugs

interleukin (IL)−17

Articles mentioning interleukin (IL)−17

Design and methods of the Ixekizumab Diabetes Intervention Trial (I-DIT): protocol for a phase 2, randomised, multicentre, placebo-controlled, double-blind trial of anti-interleukin 17 as a treatment option for adults with new-onset type 1 diabetes